WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
21hon MSN
A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...
A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition ...
The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's ...
The new skull exhibits a long, pointed beak and a brain shape unique among all known birds previously discovered from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results